Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 11.447% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) O=C(NCC1CCCO1)c1ccc(Cl)c(F)c1F
b.) CCCCN(CC)CCNc1c(N2CCN(C(=O)OCC)CC2)c(=O)c1=O
c.) CCOC(=O)c1c(C)[nH]c(C(=O)OCC(=O)Nc2cc(C)c(Cl)cc2OC)c1C
Answer: b. CCCCN(CC)CCNc1c(N2CCN(C(=O)OCC)CC2)c(=O)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CC)CCNc1c(N2CCN(C(=O)OCC)CC2)c(=O)c1=O
CCCCN(CC)CCNc1c(N2CCN(C(=O)OCC)CC2)c(=O)c1=O
ethyl 4-[2-[2-[butyl(ethyl)amino]ethylamino]-3,4-dioxocyclobuten-1-yl]piperazine-1-carboxylate